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RAPID COMMUNICATION
Angiotensin IT-stimulated hypertrophy of LLC-PK1 cells depends
on the induction of the cyclin-dependent kinase inhibitor p27''
GUNTER WOLF and ROLF A.K. STAHL
Department of Medicine, Division of Nephrology and Osteology, University of Hamburg, Hamburg, Germany
Angiotensin Il-stimulated hypertrophy of LLC-PK1 cells depends on
the induction of the cyclin-dependent kinase inhibitor p27'. Angioten-
sin II (Ang II) induces hypertrophy of cultured proximal tubular epithelial
cells including the LLC-PK1 cell line. We have previously shown that this
hypertrophy appears in the G1-phase of the cell cycle. Since progression
through the cell cycle is controlled by a series of cyclin and cyclin-
dependent kinase (CdK) complexes that may be inactivated by CdK
inhibitors, we studied the expression of the CdK-inhibitor p27K in
LLC-PK1 cells challenged with Ang II. Compared to cells grown in
serum-free medium, Ang II treatment enhanced p27KPI protein, but not
mRNA expression. This p27'°' induction was mediated through AT1-
receptors. Exogenous TGF-13 also stimulated p271° protein expression.
Immunoprecipitation experiments revealed that p271°'1 preferentially
associated with CdK4 in Ang IT-treated LLC-PK1 cells and that the activity
of this kinase was inhibited after Ang Il-treatment, an effect that may be
generated by increased p27°°1 binding to cyclin D1-CdK4 complexes. In
contrast, 27KiPI was not associated with cyclin E-CdK2 complexes in Ang
Il-stimulated cells. Treatment of LLC-PK1 cells with p27'1 antisense, but
not missense, oligonucleotides abolished the Ang IT-mediated cell hyper-
trophy as measured by de nova protein synthesis and total protein content,
and facilitated entry into the S-phase of the cell cycle. Our findings suggest
that Ang II stimulates p27'°" expression in renal cells. Furthermore, this
induction of the CdK-inhibitor appears pivotal in the hypertrophy induced
by Ang II and elucidates the molecular mechanisms associated with this
growth response in proximal tubular cells.
Orderly cell division depends on the progression of cells
through a cycle of successive phases [1, 2]. Quiescent, nondividing
cells enter the cell cycle from the G0-phase, pass through G1,
initiate their DNA synthesis in the S-phase, and after progressing
through G2, enter mitosis. The cell cycle machinery is composed
of a series of serine-threonin kinases called cyclin-dependent
kinases (CdKs) [3]. These kinases play a pivotal role by driving the
cell cycle through all major restriction points, including the G1 to
S and G2 to mitosis transitions [1• Two different subunits, the
catalytic unit CdK and a cyclin, constitute a functional CdK.
Although the activation of CdKs is subject to multiple levels of
regulation, recently a new class of low molecular weight regulatory
proteins that control cell cycle progression by binding to and
inactivating CdKs has been identified [5—7].
We and other have previously shown that the vasoactive factor,
angiotensin II (Ang II), stimulates cellular hypertrophy of cul-
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tured LLC-PK1 cells, a well-characterized cell line with some
features reminiscent of proximal tubules [8, 91. Ang Il-treated
proximal tubular cells are clamped in the G1-phase of the cell
cycle and increase their size and protein synthesis without pro-
gressing towards the S-phase of the cell cycle [8]. Since p27"°' is
important in the regulation of cyclin-CdK complexes which are
active at the G1-S-phase transition [10, 11], we investigated
whether p27'<"1 expression in LLC-PK1 cells is modified by Ang
II. Furthermore, we used an antisense approach to interfere with
p27 induction in LLC-PK1 cells. Our data demonstrate for the
first time that Ang Il-stimulates p27" protein expression in
LLC-PK1 cells, and that this induction of the CdK inhibitor is a
necessary prerequisite for the subsequent generation of tubular
hypertrophy.
Methods
Cell culture
LLC-PK1 cells are a permanent, well-characterized proximal
tubular cell line from the pig that also expresses some character-
istics of cells from the distal nephron [12, 13]. The used clone of
LLC-PK1 cells express Ang Il-receptors of the AT1-type, and Ang
II stimulates cellular hypertrophy of these cells [81. LLC-PK1 cells
were grown in Dulbecco's modified Eagle's medium (DMEM;
Gibco, Eggenstein, Germany) supplemented with 100 units/mI
penicillin, 100 ig/ml streptomycin, and 10% heat-inactivated fetal
calf serum (FCS; Gibco). Cells were cultured at 37°C in 5% CO2
and were passaged every five to seven days by light trypsination.
Western blots and immunoprecipitations
A total of lilY' quiescent LLC-PK1 were treated for eight hours
in serum-free DMEM with i0 to i0' M Ang II (Sigma,
redissolved in culture medium) in the presence or absence of 10-6
M of the AT1 -receptor blocker losartan (gift from MSD, Munich,
Germany). Additional cells were stimulated with I ng/ml ultra-
pure human TGF-p1 (Genzyme, Boston, MA, USA). LLC-PK1
cells were also stimulated with Ang II in the presence of 30 j.g/m1
of a neutralizing anti-TGF-f31_3 monoclonal antibody (Genzyme).
After washing in PBS, cell monolayers were directly lysed in 150
1.d of a buffer containing 2% SDS, 60 ms Tris-HC1 (pH 6.8), 100
mM dithiothreitol, and the protein content was measured by a
modification of the Lowry method that is insensitive to the
concentrations of SDS and dithiothreitol [14]. Protein concentra-
tions were adjusted to 100 jig/sample, 5% glycerol/0.03% bromo-
phenol blue were added and samples were boiled for five minutes.
After centrifugation, supernatants were loaded onto a denaturing
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12% SDS-polyacrylamide gel. Low molecular weight markers
(Rainbow markers; Amersham, Braunschweig, Germany), which
comprise 2,350 to 45,000 Daltons served as the molecular weight
standards. After the completion of electrophoresis, proteins were
electroblotted to a nitrocellulose membrane (Hybond-N, Amer-
sham). The blots were blocked in 8% nonfat dry milk in PBS with
0.1% Tween 20 for one hour at room temperature. For the
detection of p27'' protein, a 1:2500 dilution of a mouse
monoclonal antip27l1'l antibody (Transduction Laboratories,
Lexington, MA, USA) was used. This antibody was generated
against full-length mouse p27'', and is cross reactive with a
variety of different species including rat, dog, chicken, and hu-
mans. This antibody does not react with other CdK inhibitors
according to the manufacturer's description. A horseradish per-
oxidase-conjugated polyclonal anti-mouse antibody (Transduction
Laboratories) was used as a secondary antibody. The ECL reagent
(Amersham) was applied as a detection system exactly as recom-
mended by the manufacturer. Western blots for p27' were
repeated four times with qualitative similar results. Exposed films
from selected blots were scanned by laser densitometry (densi-
tometer GS 300; Hoefer Scientific Instruments, San Francisco,
CA, USA) to quantify bands.
For immunoprecipitation experiments, cells were stimulated
with a single dose of io— M Ang II for 8 and 24 hours (anti-CdK4
immunoprecipitation experiments) or iQ M Ang II in the
presence or absence of 10% FCS (anti-cyclin E, and anti-CdK2
immunoprecipitations), and lysed at the end of the incubation
period in 200 al cold immunoprecipitation buffer (1% Triton
X-100, 150 mivi NaC1, 10 mi Tris-HCI; pH 7.4,1 mM EDTA, 1 mM
EGTA, 0.2 m sodium vanadate, 0.2 ms phenylmethylsulfonyl
fluoride, and 0.5% NP-40). After centrifugation, 100 rl of the
supernatant was transferred to a new tube, and 5 rg of either
monoclonal mouse anti-CdK2, anti-CdK4 (both Transduction
Laboratories), or rabbit polyclonal anti-cyclin E (antibody M-20;
Santa Cruz Biotechnology, Santa Cruz, NM, USA), 400 jrl
distilled water, and 500 j.d immunoprecipitatiori buffer were
added. After incubation in a shaken ice-bath for one hour, 50 1.d
S. aureus Cowan strain (Calbiochem-Novabiochem, Bad Soden,
Germany) was added, and tubes were incubated with agitation for
another one hour. Precipitates were then washed three times with
immunoprecipitation buffer, and recovered pellets were sus-
pended in 50 1.d electrophoresis buffer [2% SDS, 60 mM Tris-HC1
(pH 6.8), 100 mi dithiothreitol, 5% glycerol, 0.03% bromophenol
blue], boiled for five minutes, centrifuged, and supernatants were
finally loaded onto a 12% SDS-polyacrylamide gel. After Western
blotting as described above, membranes were incubated with the
mouse monoclonal anti-p271 antibody to detect immune com-
plex-associated p27K. For these experiments, a horseradish
peroxidase-conjugated anti-mouse antibody was used as the sec-
ondary antibody. Immunoprecipitation experiments with subse-
quent Western blotting were independently performed three
times with qualitative similar results.
Northern hybridizations and cDNA amplification
Quiescent LLC-PK1 cells were stimulated in serum-free me-
dium for 8 and 24 hours with a single dose of 10 M Ang II or I
ng!ml TGF-f3. After being washed in RNAse-free PBS, cells were
subsequently directly lysed in 4 M guanidinium isothiocyanate, 25
m sodium citrate (pH 7.0), 0.5% sarcosyl, and 0.1 M 2-mercap-
toethanol. Total RNA was isolated by repeated phenol-chioro-
form extractions and isopropanol precipitations [151. Twenty
micrograms of total RNA were denatured by heating in form-
amide/formaldehyde at 65°C for 20 minutes and then electropho-
resed through a 1.2% agarose gel containing 2.2 M formaldehyde.
The RNA was then vacuum blotted onto a nylon membrane
(Zetabind; Cuno, Meriden, CA, USA), and filters were UV
cross-linked with 120.000 rJ/cm2 (Stratalinker; Stratagene, Hei-
delberg, Germany). A murine p27' cDNA was constructed
based on the published sequence [10]. Therefore, 500 ng of a
mouse fibroblast cDNA was amplified with the polymerase chain
reaction. A total of 0.15 jig of each of the following specific mouse
p27'<P' primers were used: 5'GTCTAACGGGAGCCCGAGC-
CTGG3' and 5'GAAGGCCGGGCTT'CTTGGGCG3'. Amplifi-
cation reaction were performed with the GeneAmpTM kit (Perkin
Elmer Cetus, Uberlingen, Germany) exactly as previously de-
scribed [16]. A total of 35 cycles was performed with an annealing
temperature of 60°C for 1.5 minutes, an extension step at 72°C for
1.5 minutes, and a denaturation step at 92°C for 1.5 minutes.
Agarose gel electrophoresis revealed a single band exactly of the
predicted 560 bp, and the specific p27K amplification product
was subcloned into the pCR II vector (Invitrogen, San Diego, CA,
USA). Sequencing with the dideoxy chain termination method
revealed that the amplified eDNA was exactly identical to the
reported sequence for murine p27"wl. The eDNA insert was
labeled with [32P]dATP (3,000 Ci/mmol; Amersham) using hex-
amer primes. Prehybridization, hybridization, washes, and auto-
radiography were performed as previously described in detail [17].
To control for small variations in RNA loading and transfer,
stripped filters were rehybridized with a 2.0 kb eDNA insert of the
plasmid pMCI encoding the murine ribosomal 18 S band. North-
ern hybridization experiments were performed twice.
To detect minor changes in mRNA expression, semiquantita-
tive cDNA amplification was performed exactly as previously
described using the housekeeping transcript GAPDH as a control
[16]. cDNA was synthesized from 10 jig of total RNA with 0.7 jig
of poly-d(T)primer (Pharmacia-LKB, Freiburg, Germany) in the
presence of 500 U of Moloney niurine leukemia virus reverse
transcriptase. Five mieroliters of the eDNA templates were used
for all amplifications. Reactions were performed for 35 cycles
exactly as described above using either the p27" primers or
primers specific for GAPDH (5'AATGCATCCTGCACCAC-
CAA3', 5' GTAGCCATATTCATFGTCATA3'). Bands of the
predicted size (p271", 560 bp; GAPDH, 512 bp) were photo-
graphed with Polaroid 55 negative film, and the reaction products
on the film were scanned by densitometry. We have demonstrated
in previous experiments, through Southern blotting of reaction
products and hybridization with predicted internal, end labeled
oligonucleotides, the identity of the GAPDH amplification prod-
uct [16]. cDNA amplifications were performed twice.
Tyrosine kinase assay
Since it has been previously reported that p27' binds to
CdK-cyclin complexes and inhibits their enzyme activity [6, 18],
kinase activity was measured in LLC-PK1 lysates immunoprecipi-
tated with an anti-CdK4 antibody. LLC-PK1 cells were stimulated
for eight hours with iO M Ang II as described above, and
immunoprecipitations were performed with the anti-CdK4 anti-
body. Washed pellets were redissolved in assay buffer (60 ms
Tris-HCI (pH 7.3), 1 mivi dithiothreitol, and 100 m sodium
orthovanadate). Tyrosine kinase activity was measured with a
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non-radioactive assay kit using the substrate PKSI which corre-
sponds to the amino acids 6 to 20 of p34"'2 (Tyrosine Kinase
Assay Kit; Boehringer, Mannheim, Germany). This kit detects
down to 0.1 M phosphate incorporated into the substrate.
Tyrosine kinase activity was calculated as n substrate phosphor-
ylated per mg protein. Kinase assays were performed three times
with triplicates for each measurement.
antisense and missense oligonucleotides
p271<Pl antisense and missense oligonucleoside phosphorothio-
ates were prepared on an Oligo 1000 DNA synthesizer (Beck-
mann Instruments, Fullerton, CA, USA) using phosphoramidite
chemistry and sulphurization with the Beaucage reagent (Glen
Research, Sterling, VA, USA). Sulfur-modified oligonucleotides
were deprotected with ammonium hydroxide and purified on
PolyPakTM cartridges. The following murine sequences were
used:
Antisense p27KP1 5'UGGCUCUCCUGCGCC3'(targets base
pairs 306 to 320)
Missense p27KiPl 5 'UCCCUUUGGCGCGCC3'
These sequences have been previously used to synthesize
oligonucleotides to interfere with p27KPI expression in murine
fibroblasts [18].
Measurement of cellular hypertrophy
For the present study, de novo protein synthesis and total
protein content were measured as two parameters of cellular
hypertrophy. We have previously shown that de novo protein
synthesis and total protein content of proximal tubular cells
closely correlate with other parameters of cellular hypertrophy
such as cell size and total RNA synthesis [8, 17]. In accordance
with our previous investigations, incorporation of [3H]leucine was
used to assess de novo protein synthesis [8, 17]. LLC-PK1 cells
(10) were plated per well in 24-well plates, and made quiescent
for 12 hours in serum-free DMEM. Cells were than transfected
with 1 j.M of either p27'' antisense or missense oligonucleotides
using lipofectin as described [19]. After another 12 hours, the
medium was renewed and cells were stimulated for 24 hours with
a single dose of i07 M Ang II. Five microcuries of [3H]leucine
(142 Ci/mmol, Amersham) were included per well for the last 12
hours exactly as previously described [17]. The cells were washed
twice in ice-cold PBS and proteins were then precipitated with
ice-cold 10% trichloracetic acid. Proteins were redissolved in 0.5
M NaOH containing 0.1% Triton X-100, and radioactivity was
measured by liquid scintillation spectroscopy after adding 5 ml
RotiszintTM scintillation cocktail (Roth, Karlsruhe, Germany).
[3H]leucine incorporation experiments were independently re-
peated five times with duplicate measurements for each experi-
ments.
In addition to de novo protein synthesis, total protein content
was measured. The stimulation was exactly performed as de-
scribed for the de nova protein synthesis measurement with the
modification that the radioactive [3H]leucine was omitted. After
stimulation for 24 hours, cells were washed twice in ice-cold PBS,
and proteins were directly lysed in 0.5 M NaOH. Protein content
of samples was measured with the Lowry method using human
albumin as a standard [14].
Measurement of cellular proliferation
The incorporation of [3H]thymidine into DNA was used as a
measurement of progression of cells into the S-phase of the cell
cycle. A total of io LLC-PK1 cells were transferred into each well
of a 96-well cell culture plate, rested in serum-free DMEM
medium for 12 hours, and were subsequently transfected with 1
jIM p27KiPl antisense or missense oligonucleotides as described
above. After renewing the medium, cells were stimulated for
another 24 hours with a single dose of io— M Ang II. Cells were
pulsed with I jICi/well 3[H]thymidine (Amersham) during the last
eight hours of culture. After pulsing with [3H]thymidine, cells
were washed twice in PBS, tiypsinated for 10 minutes at room
temperature, and finally collected on glass-fiber paper with an
automatic cell harvester. Radioactivity of dry filters was deter-
mined by liquid scintillation spectroscopy in the presence of 5 ml
scintillation fluid. Experiments were independently repeated four
times with four duplicates for each experiment.
Statistical analysis
Results are expressed as means SEM. Statistical significance
between multiple groups was first tested with the nonparametric
Kruskal-Wallis test for multiple comparisons. Individual groups
were then tested with the Wilcoxon-Mann-Whitney test. A value
of P < 0.05 was considered significant.
Results
We first tested whether treatment of LLC-PK1 cells with 10—6
and io M Ang II, a dose previously shown to stimulate
hypertrophy of this cell line, may influence p27P protein levels.
As shown in Figure 1, these doses of Ang II for eight hours
significantly stimulated p27K protein expression. In addition, 1
ng/ml TGF-j31 also augmented p27( expression as determined
by Western blotting of whole cellular protein lysates (Fig. 1).
Co-incubation of cells with the AT1-receptor antagonist losartan
abolished this Ang IT-mediated increase in p271 protein expres-
sion indicating the specificity of the response (Fig. 1). Co-
incubation of LLC-PK1 cells with 106 M Ang TI and a neutralizing
anti-TGF-313 reduced p27K protein expression by less than
10% as measured by laser densitometry (Western blot not shown).
This finding suggests that Ang TI-induced p27' expression is not
mediated by stimulated TGF-J3 expression. However, in contrast
to protein expression, iO M Ang IT for eight hours did not
influence p27' mRNA expression as detected by Northern
blotting (Fig. 2). To test whether minor changes in p27"
transcript expression take place after stimulation of LLC-PK1
cells with Ang II or TGF-13, a semiquantitative eDNA amplifica-
tion of reverse transcribed RNA was performed using GAPDH as
a control. However, as shown in Figure 3 no changes in p27"
mRNA expression were detected in LLC-PK1 cells after stimula-
tion for 8 to 24 hours with Ang II or TGF-/3. These observations
are in agreement with recent investigations demonstrating that
p27'' expression is principally regulated on a post-transcrip-
tional level [18, 20].
Since it has been previously reported that p27KPl binds to
cyclin-CdK complexes and inhibits their activity [5, 6, 21], we
immunoprecipitated CdK4 and probed precipitates with the anti-
p27' antibody to determine how much p27''1 is associated
with Cdk4. Figure 4A reveals that Ang II for eight hours
stimulates association of p27'<'1 with CdK4. This effect was less
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Fig. 1. Western blot for p27'°'
protein. LLC-PK1 cells were
stimulated for eight hours with a
single dose of iO- to 106 M Ang II
in the presence or absence of 106 M
of the specific AT1-receptor
antagonist losartan. A total of 100 jg
protein from each cellular lysate were
subjected to electrophoresis. Ang II
treatment of quiescent LLC-PK
induced p27'" expression. This
induction was abolished in the
presence of losartan suggesting signal
transduction through the AT1-
receptor. One nglml of TGF-131 for
eight hours also stimulated 27KP1
protein expression. The blot is
representative of four independent
experiments with qualitativc similar
changes.
visible after 24 hours of incubation (Fig. 4A). However, immuno-
precipitation with an anti-cyclin E antibody with subsequent
Western blotting for p27° revealed that, although 10% FCS
leads, as predicted, to a decrease in cyclin E-CdK2-associated
p27'(Pl, Ang II failed to up-regulate the amount of p271 being
complexed with cyclin E-CdK2 (Fig. 4B). Similar results were
obtained when an anti-CdK2 antibody was used instead of the
anti-cyclin E serum to precipitate CdK2-cyclin E complexes (data
not shown).
To further investigate whether this binding may also function-
ally inhibit CdK4 enzyme activity, tyrosine kinase activities were
measured in anti-CdK4 immunoprecipitates using a novel non-
radioactive tyrosine kinase assay. Stimulation of LLC-PK1 cells
for eight hours with i07 M Ang II significantly inhibited tyrosine
kinase activities in CdK4 precipitates (controls, 32.03 1.13, iO
M; Ang II, 19.73 1.05 n substrate phosphorylated/mg protein;
P < 0.01 vs. controls, N = 3).
To test whether interference with p27''1 expression using an
antisense oligonucleotide approach may influence Ang Il-stimu-
lated hypertrophy, de novo protein synthesis and total protein
content was measured in LLC-PK1 cells transiently transfected
with 1 ILM of 27kiPl antisense or missense oligonucleotides. We
applied phosphorothioate-modified oligonucleotides which have
sequences previously used successfully to abrogate p27KPl protein
expression in murine fibroblasts [18]. As demonstrated in Figure
5A, antisense treatment of LLC-PK1, but not missense oligonu-
cleotides, partly abolished the Ang 11-stimulated de novo protein
synthesis as measured by [3H]leucine incorporation. In parallel,
antisense oligonucleotides partly inhibited the increase in total
protein content induced by i0— M Ang II (Fig. 5B). We have
previously shown that Ang II slightly inhibits proliferation of
LLC-PK1 cells, a mechanism most likely mediated by autologous
induction of TGF-131 reflecting G1-phase arrest during induction
of hypertrophy. Ang II (10 to 10 M) inhibited, as predicted,
mitogenesis in 27K missense oligonucleotide treated LLC-PK1
cells as measured by [3H]thymidine incorporation (Table 1).
Fig. 2. Northern blot for p2 71C1 . In contrast to protein expression, treat-
ment of LLC-PK1 cells with 1 0 M Ang II for eight hours does not change
27K1 transcript expression. The filter was rehybridized with a cDNA
encoding for the ribosomal 18 S RNA to detect small variations in loading
and transfer efficiency. This blot is representative of two experiments.
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Controls 8 hr
1 ng!mITGF-38hr
to— M Ang II 8 hr
Controls 24 hr
However, preincubation of LLC-PK1 cells with 1 I.LM p27'<'
antisense oligonucleotides abolished this inhibition of prolifera-
tion, demonstrating that abrogation of Ang 11-mediated p27K1)
expression facilitates the G1-phase exit (Table 1).
Discussion
We are interested in the growth promoting effects of the
vasoactive peptide Ang II and have previously demonstrated that
Ang II stimulates cellular hypertrophy of different cultured prox-
imal tubular cells including LLC-PK, cells [8, 17, 221. Others have
confirmed these findings [9, 23]. Ang Il-stimulated proximal
tubular cells are clamped in the 01-phase of the cell cycle and
increase their size, protein and total RNA content without
progressing towards the S-phase of the cell cycle [8, 17, 22]. The
Ang lI-mediated hypertrophy of cultured proximal tubular cells
partially depends on the induction and autocrine action of TGF-/3
[24]. Understanding the molecular mechanism of Ang Il-induced
hypertrophy of proximal tubular cells is important because this
growth response has been implicated in the progression of chronic
renal disease [reviewed in 25].
Major progress in the molecular biology of cell cycle control,
originally obtained from studies in yeast, have provided a close
frame work how progression through the cell cycle is governed. In
mammalian cells, progression from G to S-phase, in which DNA
synthesis occurs, is regulated by the accumulation of cyclins D, E,
and A [1—4]. These cyclins bind and activate different CdK
catalytic subunits and the complex of cyclin and CdK eventually
phosphorylates subsequent target proteins like the protein prod-
uct of the retinoblastoma protein, and transcription factors being
involved in the regulation of immediate early genes [2]. The cyclin
D-CdK4 and cyclin E-CdK2 complexes are catalytically active
during the late G1 phase and are implicated in the regulation of
G1/S transit. Studies during the last few years have revealed that
CdK activity is regulated by association with inhibitory proteins
Fig. 3. Semiquantitative cDNA
amplification of reverse transcribed
mRNA: Amplification of the
housekeeping gene GAPDH sei-eed as
a control. As can be already seen by
inspection, no change in p27<l
mRNA expression was detected in
LLC-PK1 cells treated for 8 to 24
hours with io- M Ang II or 1 nglml
TGF-131. Densitometry analysis of
specific bands on negative film and
calculating a p27'<"1/GAPDH ratio
also demonstrated no major changes
in p27'K'Pl transcript expression (data
not shown). Stimulation of cells,
reverse transcription, and cDNA
amplification was independently
performed twice.
[5—7]. p21 was the first identified member of such proteins know
called CdK inhibitors [5—7, 26]. These CdK inhibitors can be
grouped in two classes: whereas p15, p16, and p18 specifically
inhibit CdK4 and CdK6 by direct binding to the catalytic CdK
subunit alone; interact and inhibit the proteins p21, p27', as
well as p28 with a broad range of CdK-cyclin complexes [5, 6].
p27'<°' is associated predominantly with cyclin D-CdK4, but
shows the ability to inhibit a variety of cyclin-CdK complexes [10,
11]. The 27Kt1 protein is implicated in the negative regulation of
G1 progression in responses to a number of antimitogenic signals
[5, 6]. In general, deprivation of serum mitogens and/or G1-phase
arrest by antiproliferative factors is associated with increased
levels 0f27K protein [18, 20, 27]. It has been shown in different
cell types that these p27lK accumulation depends on transla-
tional control since mRNA expression remains unchanged [18,
20]. It is commonly accepted that such increased p27Kri levels
bind to and inhibit cyclin-CdKs complexes resulting in G1-phase
arrest of the cell cycle [5, 6]. However, the inhibition of CdKs by
p27<Pl is complex, subject of ongoing studies, and may be
influenced by the specific antimitogenic factor. For example,
inducers of cAMP prevent G1 progression in cytokine stimulated
macrophages, and although cyclin D1-CdK4 complexes assembly
normally in cAMP-treated cells, they remain catalytically inactive
[28]. Inducers of cAMP increase overall level of p27', and more
p27'' associates in complexes with cyclin D1-CdK4 [28]. In
contrast, in lung mink epithelial cells, a cell line particularly
sensitive to TGF--mediated cell cycle arrest, p27K preferen-
tially bind and inactivates cyclin E-CdK2 complexes [29]. There-
fore, under circumstances in different species where certain
cyclin-CdK complexes are more prevalent than others, simple
mass action may determine distribution of p27"' among them.
Since Ang Il-mediated hypertrophy of proximal tubular cells is
associated with G1-phase arrest, we were interested to study
whether Ang II influences p27'<'1 levels in LLC-PK1 cells. Our
results demonstrated that Ang II induces p27Kl protein, but not
1 ng/ml TGF-13 24 hr
lO7MAngll
p271<'P1 560 bp
GAPDH 512bp
A Controls 8 hr
Ang II 8 hr
Controls 24 hr
I —
Controls 8 hr
10% FCS 8 hr
Ang II 8 hr
10% FCS + Ang 118 hr
a
— p27P1
46 — —
30
21.5
— p2$Pl
kDa
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Fig. 4. Immunoprecipisation experiments with subsequent Western blotting
and detection with a p.27" antibody. A. Total cellular lysates were
immunoprecipitated with an anti-CdK4 antibody. Subsequent Western
blotting revealed more p27''' binding to the precipitated CdK4 com-
plexes in LLC-PK1 cells treated for eight hours with i0 M Ang II
compared with controls incubated in serum-free medium. After 24 hours
of stimulation, there was still a small increase in p27'°"' binding to CdK4
complexes in Ang 11-treated cells. B. In contrast, immunoprecipitation
with an anti-cyclin E antibody revealed no increase in p27'4' association
with cyclin E-CdK2, although 10% FCS reduced, as predicted, the amount
of p27KPl bound to cyclin E. Moreover, co-incubation of LLC-PK1 cells
with 10% FCS and io— M Ang IT does not result in an increase in cyclin
E-associated p2714" compared with cells treated with 10% FCS only.
Almost identical results were obtained when an anti-CdK2 monoclonal
antibody was used instead of the anti-cyclin E serum for the immunopre-
cipitations (data not shown). Immunoprecipitation experiments with
subsequent Western blotting were independently performed three times
with qualitative similar results.
mRNA levels in these cells. This effect was specific and trans-
duced by AT1-receptors. Although baseline expression of p27'°"
occurs in LLC-PK, cells grown in serum-free DMEM, Ang II
significantly stimulated p27'" protein levels. These findings may
suggest that LLC-PK1 cells, even grown in serum-free DMEM,
may slowly progress through the cell cycle, and that this progres-
sion is inhibited in the presence of Ang II. Furthermore, we have
partially investigated whether p27" interferes with distinct
Fig. 5. Effect of p2 74'1 antisense and missense phosphorothioate oligonu-
cleotides on selected parameters of Ang 11-mediated hypertrophy. Symbols
are: () control; (•) Ang Ii. Measurement of de novo protein synthesis as
[3H]leucine incorporation (A) and total protein content (B). Transient
transfection with 1 J.LM antisense, but not missense oilgonucleotides
abolished the de novo protein synthesis (A) and increase in total protein
content (B) induced by iO M Ang IT. N 5 independent experiments
with duplicate measurements, *p < 0.001 versus unstimulated controls,
#P < 0.05 versus Ang lI-treated LLC-FK, cells transfected with 27K1
missense oligonucleotides.
cyclin-CdK complexes. Immunoprecipitation experiments with
subsequent Western blotting using anti-p27'" antibodies re-
vealed that more p27'' is bound to CdK4 after stimulation with
Ang II. Applying a non-radioactive kinase assay, anti-CdK4
immunoprecipitates from Ang Il-treated LLC-PK, cells exhibited
less kinase activity than precipitates from control cells. These
findings may suggest that an increase in p27'' abundance
induced by Ang II, interacts and inhibits cyclin D1-CdK4 com-
plexes. However, further studies are necessary to proof whether
the inhibition of CdK4 in Ang Il-treated LLC-PK1 cells is actually
due to p27KiPl binding. In contrast, immunoprecipitation with an
anti-cyclin E antibody with subsequent p27''' detection revealed
that, although 10% FCS leads to a decrease in cyclin E-CdK2
associated p27'°' binding, Ang II had no effect in up-regulating
A
6 *
5
0
Antisense Missense
B *
0.10
0.08
I
0.02
0.00•— —
Antisense Missense
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Table 1. Effect of p27Kl antisense and missense phosphorothioate
oligonucleotides on 3[Hthymidine incorporation of LLC-PK1 cells
treated with Ang II
Controls + antisense 4414 667
10— M Ang II + antisense 5002 560
iO M Ang II + antisense 5596 879
10' M Ang II + antisense 3682 566
Controls + missense 3392 165
10 M Ang II + missense 4045 384
i0 M Ang II + missense 2124 216
106 M Ang II + missense 1616 52P
cpm/well, P < 0.05 versus controls, N = 4 with four replicates for each
experiment
p271 binding to cyclin E-CdK2 complexes compared with
control medium. These observations suggest that Ang 11-mediated
cellular hypertrophy in LLC-PK1 cells is preferentially mediated
by binding of p27' to cyclin D1-CdK4 complex, and not by
interference with cyclin E-Cdk2. Furthermore, a neutralizing
anti-TGF-1313 antibody, exhibited only very minor effects (reduc-
tion of less than 10% of the Ang TI-induced p27KPI expression)
on Mg Il-mediated p27KtI accumulation in LLC-PK1 cells,
suggesting that the effects of Ang II are not simply explained by
endogenous activation and autocrine function of TGF-13.
More direct evidence that induction of p27K is pivotal in the
Mg TI-stimulated hypertrophy of LLC-PK1 cells stems from the
antisense experiments. We applied phosphorothioate-modified
oligonucleotides based on the murine sequence because porcine
p27' is not yet cloned. This antisense oligonucleotides have
been previously demonstrated to inhibit p27' expression in
Balb/c-3T3 fibroblasts and prevented cell cycle arrest in response
to mitogen depletion in these cells [18]. Although we have not
directly measured the cellular incorporation of the oligonucleo-
tides, our results convincingly demonstrated that lipofectin-medi-
ated transfection of LLC-PK1 cells with p27' antisense, but not
with missense oligonucleotides prevented Ang Il-induced cellular
hypertrophy as measured by protein de nova synthesis and total
protein content. Moreover, treatment with p27'1 antisense
oligonucleotides revoked G1-phase cell cycle arrest in Ang II-
treated cells and facilitates entrance into the S-phase as deter-
mined by [3Hlthymidine incorporation. However, since the se-
quences of the used oligonucleotides are derived from mouse, a
total inhibition of 27K1 expression may not occur in the porcine
cell line LLC-PK1. Therefore, this species difference may partly
explain why the Ang IT-stimulated hypertrophy in porcine LLC-
PK1 cells was not totally abolished by antisense oligonucleotides
derived from the murine p27Tl sequence. In addition, we cannot
exclude that other redundant CdK inhibitors such as p21 may be
stimulated by Ang IT treatment of LLC-PK1 cells. Nevertheless,
our results indicate that although Ang IT-mediated induction of
27K is important in G1-phase arrest with subsequent hyper-
trophy, LLC-PK1 cells would progress towards the S-phase after
treatment with Ang II. Therefore, it is tempting to speculate that
the Aug IT mediated signals causing G0-phase exit and entering
the cell cycle are not necessarily identical with the induction of
p27 protein, which then clamps cells in the G1-phase.
Recently, three different groups have reported the generation
of p27''1 knock-out mice [30—32]. These mice are larger than the
control animals and this enlargement is caused by increases in
total cell number in almost every organ. Unexpectedly, at least in
lymphocytes, cell cycle arrest mediated by TGF-/3 remained intact
in p271-deficient mice, suggesting that probably redundant
pathways with other CdK-inhibitors are involved [30, 31]. More-
over, 27K11 protein expression was rather low in normal kidneys
[30]. Although these findings from transgenic mice lacking p27°
do not argue against a role of this protein in renal hypertrophy,
the in vivo situation is certainly more complex as predicted from
cell culture studies and our in vitro experiments need to be
clarified in established animal models of tubular hypertrophy.
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